Evidence map›Paper›PMID 40153521›Full record

ReviewAngewandte Chemie (International ed. in English)2025

Supramolecular Gels as Active Tools for Reaction Engineering.

David K Smith

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Fluorescent Supramolecular Gels Based on D-Sorbitol Derivatives.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  4. Article
  5. Article
  6. The Ascent of Supramolecular Polymers and Gels in Asymmetric Catalysis.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  7. Supramolecular Gels as Active Tools for Reaction Engineering.Angewandte Chemie (International ed. in English) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David K SmithDepartment of Chemistry, University of York, Heslington, York, YO10 5DD, UK.

Funding

EPSRC EP/X02895X/1Horizon Europe Marie Skłodowska-Curie Action
6 · The paper itself

Abstract

Supramolecular gels, assembled from low-molecular-weight gelators (LMWGs), are fascinating soft materials for use in synthesis, combining aspects of hetero- and homogeneous systems. The unique combination of environments within a gel offers the ability to control reactivity in new ways. For example, self-assembly into a gel network can modify the reactivity of catalytic sites on the LMWG. Controlling the assembly of multiple LMWGs can result in integrated gels with orthogonal activities that could not normally coexist. Enzymes encapsulated within self-assembled gels can exhibit superactivity, extending their use into solvent media more appropriate for organic synthesis. Highly reactive species, such as ligand-free nanoparticles or moisture/air-sensitive organometallics, can be protected within the unique environment of a supramolecular gel, facilitating their use in ambient conditions, potentially opening up the use of such species to nonspecialist researchers. Beyond fundamental chemistry, performing reactions in gels leads to the emerging concept of gels as "nanoreactors". Smart chemical engineering methods are enabling the fabrication of materials and devices for use in a variety of synthetic workflows, potentially transforming the way synthesis is done. In summary, this review provides an overview of key concepts and signposts the way toward future developments of gels as active tools for reaction engineering.

Indexed as

CatalysisGelsSelf‐assemblySupramolecularSynthesis

Identifiers

PMID40153521
PMCPMC12144879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.